Macular Disease Foundation Australia logo

    MDFA News

    Macula Month 2022

    We kick off Macula Month celebrating a huge win for the macular disease community, as the major political parties reject a 69 per cent rebate cut for sight-saving eye injections.

    Read more
    Back

    Most recent

    Macula Matters

    Macula Matters

    Thank you for reading this version of Macula Matters, MDFA’s newsletter for healthcare professionals.

    New Chair of MDFA Board appointed

    We welcome Mr Graeme Head AO as the new Chairman of the MDFA Board.

    Researcher holding a laptop

    Optometrists needed for trial study

    Participate in new intervention designed to improve glaucoma and diabetic eye care.

    Update: Potential new treatments for nAMD and DMO

    The US FDA recently approved two treatments: Susvimo® and Vabysmo®.

    Research program: AMD and quality of life

    Volunteers with AMD sought to build a new computerised instrument.

    Reticular pseudodrusen in AMD: Update for optometrists

    Read the latest from CERA researchers Dr Zhichao Wu, Himeesh Kumar and Prof Robyn Guymer.

    MDFA advocacy update: Maintaining Australia’s world-leading nAMD outcomes

    The latest on our efforts to ensure accessible IVI for Australian patients.

    Vision Voice newsletter cover

    Vision Voice summer 2021: Read it today

    MDFA’s summer 2021 edition of Vision Voice newsletter is out now!

    Macula Matters

    Macula Matters

    In the latest Macula Matters, we cover CPD webinars, updates on the latest macular disease research, and a survey to help us work together to support patients.

    Loading...
    Loading...